Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nigeria PrEP Demonstration Study
PACTR201605001602542Recruiting
- Sponsor
- National Agency for the Control of AIDS
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by National Agency for the Control of AIDS. Started Nov 2015; status: recruiting.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR201605001602542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201605001602542.